Stock Market News

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss trial

May 12, 2025 - 01:20
 0
Read More

Tags:

Previous Article

Dollar gains versus yen on US-China trade optimism; Kiwi climbs

Next Article

CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced

Related Posts

Fanduel owner cuts US profit forecast on gamblers' winning streak

Fanduel owner cuts US profit forecast on gamblers' winn...

May 7, 2025  0

SMIC shares slump as cautious outlook eclipses strong Q...

May 9, 2025  0

Hong Kong's CK Hutchison assures legal compliance in ports deal

Hong Kong's CK Hutchison assures legal compliance in po...

May 12, 2025  0